ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,814.40
-0.85%
S&P ASX All Technology
3,045.20
-2.07%
Brent Oil
83.76
0.00%
US Dollar vs AUD
1.49165
0.00%
Bitcoin
67,121.66
0.27%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Immunome Inc (IMNM)

  7. Immunome Inc (IMNM) News

IMNM

Immunome (IMNM)

Immunome Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMNM
DateTimeSourceHeadlineSymbolCompany
18/05/202407:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
17/05/202422:00Business WireImmunome Announces Promotion of Max Rosett to Chief Financial OfficerNASDAQ:IMNMImmunome Inc
14/05/202422:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNMImmunome Inc
14/05/202422:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMNMImmunome Inc
14/05/202422:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNMImmunome Inc
14/05/202422:00Business WireImmunome Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IMNMImmunome Inc
08/05/202422:00Business WireImmunome to Present at 2024 Bank of America Healthcare ConferenceNASDAQ:IMNMImmunome Inc
02/05/202422:00Business WireImmunome Appoints Kinney Horn as Chief Business OfficerNASDAQ:IMNMImmunome Inc
25/04/202422:26Business WireImmunome Appoints Sandra M. Swain to Board of DirectorsNASDAQ:IMNMImmunome Inc
05/04/202423:00Business WireImmunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:IMNMImmunome Inc
29/03/202407:02Business WireImmunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired AssetsNASDAQ:IMNMImmunome Inc
26/03/202423:00Business WireImmunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From AyalaNASDAQ:IMNMImmunome Inc
08/03/202400:00Business WireImmunome to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:IMNMImmunome Inc
02/03/202400:00Business WireImmunome to Participate in the TD Cowen 44th Annual Healthcare ConferenceNASDAQ:IMNMImmunome Inc
22/02/202413:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
22/02/202413:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
21/02/202400:15Business WireImmunome Recognizes Ayala Pharmaceuticals’ Announced Completion of Enrollment in Phase 3 RINGSIDE Study Evaluating AL102 in Desmoid TumorsNASDAQ:IMNMImmunome Inc
17/02/202408:05Business WireImmunome Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:IMNMImmunome Inc
15/02/202408:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNMImmunome Inc
15/02/202408:09Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNMImmunome Inc
14/02/202414:38Business WireImmunome Announces Pricing of Public Offering of Common StockNASDAQ:IMNMImmunome Inc
14/02/202408:36Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IMNMImmunome Inc
14/02/202408:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNMImmunome Inc
14/02/202408:05Business WireImmunome Announces Proposed Public Offering of Common StockNASDAQ:IMNMImmunome Inc
13/02/202406:10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IMNMImmunome Inc
07/02/202400:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMNMImmunome Inc
06/02/202400:00Business WireImmunome to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology ConferenceNASDAQ:IMNMImmunome Inc
03/02/202408:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMNMImmunome Inc
01/02/202412:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
01/02/202412:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMNMImmunome Inc
 Showing the most relevant articles for your search:NASDAQ:IMNM

Your Recent History

EU
G361S
G361S
HITB
DPXUSDT
Dopex Governance Token
UNSW3
UBXTETH
NASDAQ
PRFF
BOV
KMBB34R
Kimberly Cl DRN
BIT
P1XWJ8
NLBNPIT1XWJ8 20261231 60
USOTC
ACAN
Americann (QB)
LSE
23BV
Newday Pf 28 S
LSE
BQ68
Platform 'm' 32
LSE
SD41
Oest.k. 25
USOTC
SPHXF
SM Prime (PK)
BIT
F12746
Vontobel Financial Produ...
USOTC
FMCKL
Federal Home Loan Mortgage (QB)
BIT
Q00663
Leonteq Securities
UNSW3
XMTETH
MetalSwap
BIT
P20JQ8
NLBNPIT20JQ8 20240920 40
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved